Recent Updates
Recently added Catalysts
AMGN

Amgen To Present At The Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference Amgen (NASDAQ:AMGN) will present via video conference at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference at 1 p.m. PT on...

Key Takeaway: THOUSAND OAKS, Calif. , Jan. 7, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present via video conference at the Goldman Sachs 12 th Annual Healthcare CEOs Unscripted Conference at 1 p.m. PT on Thursday, Jan. 9, 2020 . Robert A. Bradway , chairman and chief executive officer a

Full Press Release Details

THOUSAND OAKS, Calif. , Jan. 7, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present via video conference at the Goldman Sachs 12 th Annual Healthcare CEOs Unscripted Conference at 1 p.m. PT on Thursday, Jan. 9, 2020 . Robert A. Bradway , chairman and chief executive officer at Amgen, and Peter H. Griffith , executive vice president and chief financial officer at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.
About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
CONTACT: Amgen, Thousand Oaks Jessica Akopyan , 805-447-0974 (media) Trish Hawkins , 805-447-5631(media) Arvind Sood , 805-447-1060 (investors)

Related Links

21 %

Last updated: Jan 7, 2020